Prevalence of newly diagnosed diabetes in clinical settings

Reviews in Cardiovascular Medicine

Volumn 7, Issue SUPPL. 2, 2006, Pages

  Nesto, Richard W ^a  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

Acute myocardial infarction; Cardiovascular disease; Diabetes mellitus; Hyperglycemia

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYL COENZYME A; ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DALTEPARIN; DIGOXIN; DIURETIC AGENT; GLUCOSE; INSULIN; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

BLOOD CLOT LYSIS; BLOOD GLUCOSE MONITORING; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CLINICAL PROTOCOL; CLINICAL TRIAL; COMORBIDITY; CONTINUOUS INFUSION; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DEFIBRILLATION; DIABETES MELLITUS; DISEASE ASSOCIATION; DISORDERS OF CARBOHYDRATE METABOLISM; FIBRINOLYTIC THERAPY; HEALTH CARE PERSONNEL; HEART INFARCTION; HEMODYNAMIC MONITORING; HOSPITAL ADMISSION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MORBIDITY; MORTALITY; ORAL GLUCOSE TOLERANCE TEST; OUTCOMES RESEARCH; PREVALENCE; PROGNOSIS; REVASCULARIZATION; REVIEW; TRANSIENT ISCHEMIC ATTACK; TREATMENT PLANNING;

CARDIOLOGY SERVICE, HOSPITAL; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; HOSPITALIZATION; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; PATIENT CARE TEAM; PREVALENCE; TREATMENT OUTCOME;

EID: 33846464963     PISSN: 15306550     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Braunwald E. Shattuck lecture-cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med. 1997;337:1360-1369.
2. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355:773-778.
3. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359-1367.
4. Smit JWA, Romijn JA. Acute insulin resistance in myocardial ischemia: causes and consequences. Semin Cardiothor Vasc Anesth. 2006;10: 215-219.
5. Miettinen H. Lehto S, Salomaa V, et al. Impact of diabetes on mortality after the first myocardial infarction. Diabetes Care. 1998;21:69-75.
6. Prasad A, Stone GW, Stuckey TD, et al. Impact of diabetes mellitus on myocardial perfusion after primary angioplasty in patients with acute myocardial infarction. J Am Coll Cardiol. 2005;45:508-514.
7. Ishihara M, Inoue I, Kawagoe T, et al. Diabetes mellitus prevents ischemic preconditioning in patients with a first acute anterior wall myocardial infarction. J Am Coll Cardiol. 2001;38:1007-1011.
8. Malmberg K, Yusuf S, Gerstein HC, et al. Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry. Circulation. 2000;102:1014-1019.
9. Woodfield SL, Lundergan CF, Reiner JS, et al. Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience. J Am Coll Cardiol. 1996;28:1661-1669.
10. Norhammar A, Malmberg K, Diderholm E, et al. Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization. J Am Coll Cardiol. 2004;43:585-591.
11. O'Sullivan JJ, Conroy RM, Robinson K, et al. Inhospital prognosis of patients with fasting hyperglycemia after first myocardial infarction. Diabetes Care. 1991;14:758-760.
12. Lewandowicz J, Komorowski JM, Gozlinski H. Metabolic disorders in myocardial infarction. Changes in blood serum zinc, growth hormone, insulin and glucose concentration in patients with acute myocardial infarction. Cor Vasa. 1979;21:305-316.
13. Soler NJ, Frank S. Value of glycosylated hemoglobin measurements after acute myocardial infarction. JAMA. 1981;246:1690-1693.
14. Oswald GA, Smith CC, Betteridge DJ, Yudkin JS. Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction. BMJ. 1986;293:917-922.
15. Bellodi G, Manicardi V, Malavasi V, et al. Hyperglycemia and prognosis of acute myocardial infarction in patients without diabetes mellitus. Am J Cardiol. 1989;64:885-888.
16. Ravid M, Berkowicz M, Sohar E. Hyperglycemia during acute myocardial infarction. A six-year follow-up study. JAMA. 1975;233:807-809.
17. Sewdarsen M, Vythilingum S, Jialal I, Becker PJ. Prognostic importance of admission plasma glucose in diabetic and non-diabetic patients with acute myocardial infarction. QJM. 1989; 71:461-466.
18. Oswald GA, Smith CC, Betteridge DJ, Yudkin JS. Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction. BMJ. 1986;293:917-922.
19. Haffner SM, Howard G, Mayer E, et al. Insulin sensitivity and acute insulin response in African-Americans, non-Hispanic whites, and Hispanics with NIDDM: the Insulin Resistance Atherosclerosis Study. Diabetes. 1997;46:63-69.
20. McLaughlin T, Reaven G, Abbasi F, et al. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? Am J Cardiol. 2005;96:399-404.
21. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities-the role of insulin resistance and the sympathoadrenal system. N Engl J Med. 1996;334:374-381.
22. NIH. Available at: www.clinicaltrials.gov. Web site accessed October 25, 2006.
23. Lankisch M, Futh R, Schotes D, et al. High prevalence of undiagnosed impaired glucose regulation and diabetes mellitus in patients scheduled for an elective coronary angiography. Clin Res Cardiol. 2006;95:80-87.
24. Savage PD, Banzer JA, Balady GJ, Ades PA. Prevalence of metabolic syndrome in cardiac rehabilitation/secondary prevention programs. Am Heart J. 2005;149:627-631.
25. Available at: www.diabetes.niddk.nih.gov. Web site accessed October 25, 2006.
26. Bonora E, Kiechl S, Willeit J, et al. Prevalence of insulin resistance in metabolic disorders: the Bruneck study. Diabetes. 1998;47:1643-1649.
27. Kowalska I, Prokop J, Bachorzewska-Gajewska H, et al. Disturbances of glucose metabolism in men referred for coronary arteriography: post-load glycemia as a predictor for coronary atherosclerosis. Diabetes Care. 2001;24:897-901.
28. Golay A. GAMI: glucose abnormalities in patients with myocardial infarction-prevalence, diagnosis and prognostic implications. Program and abstracts from the European Society of Cardiology Congress 2004, August 28-September 1, 2004, Munich, Germany.
29. Norhammar A, Tenerz A, Nilsson G, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet. 2002;359:2140-2144.
30. Chung EH, Curran PJ, Sivasankaran S, et al. Prevalence of metabolic syndrome in patients < 45 years old with acute coronary syndrome presenting for emergent primary percutaneous intervention. J Am Coll Cardiol. 2006;47:216A.
31. Zarich S, Luciano C, Hulford J, Abdullah A. Prevalence of metabolic syndrome in young patients with acute MI: does the Framingham Risk Score underestimate cardiovascular risk in this population? Diab Vasc Dis Res. 2006;3:103-107.
32. Meier JJ, Deifuss S, Klamann A, et al. Plasma glucose at hospital admission and previous metabolic control determine myocardial infarct size and survival in patients with and without type II diabetes: the Langendreer Myocardial Infarction and Blood Glucose in Diabetic Patients Assessment (LAMBDA). Diabetes Care. 2005;28:2551-2553.
33. Suleiman M, Hammerman H, Boulos M, et al. Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction. Circulation. 2005;111:754-760.
34. Goyal A, Mahaffey KW, Garg J, et al. Prognostic significance of the change in glucose level in the first 24 hr after acute myocardial infarction: results from the CARDINAL Study. Eur Heart J. 2006;27:1289-1297.
35. Matz K, Keresztes K, Tatschi C, et al. Disorders of glucose metabolism in acute stroke patients: an underrecognized problem. Diabetes Care. 2006;29:792-797.
36. Kernan WN, Viscoli CM, Inzucchi SE, et al. Prevalence of abnormal glucose tolerance following a transient ischemic attack or ischemic stroke. Arch Intern Med. 2005;165:227-233.
37. Gray CS, Scott JF, French JM, et al. Prevalence and prediction of unrecognised diabetes mellitus and impaired glucose tolerance following acute stroke. Age Ageing. 2004;33:71-77.
38. Gentile NT, Seftchick MW, Huynh T, et al. Decreased mortality by normalizing blood glucose after acute ischemic stroke. Acad Emerg Med. 2006;13:174-180.
39. Garg R, Chaudhuri A, Munschauer F, Dandona P. Hyperglycemia, insulin, and acute ischemic stroke: a mechanistic justification for a trial of insulin infusion therapy. Stroke. 2006;37:267-273.
40. Martini SR, Kent TA. Hyperglycemia in acute ischemic stroke: a vascular perspective. J Cereb Blood Flow Metab. 2006 Jun 28 [epub ahead of print].
41. Ribo M, Molina C, Montaner J, et al. Acute hyperglycemia state is associated with lower tPA-induced recanalization rates in stroke patients. Stroke. 2005;36:1705-1709.
42. The Society of Thoracic Surgeons STS National Database. Available at: www.sts.org/sections/stsnationaldatabase/. Accessed April 4, 2006.
43. Furnary AP, Wu Y, Bookin SO. Effects of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: The Portland Diabetic Project. Endocr Pract. 2004;10:21-33.
44. Montori VM, Bistrian BR, McMahon MM. Hyperglycemia in acutely ill patients. JAMA. 2002;288:2167-2169.
45. The ACE/ADA Task Force on Inpatient Diabetes. American College of Endocrinology and American Diabetes Association Consensus Statement on inpatient diabetes and glycemic control. Diabetes Care. 2006;29:1955-1962.